
JOGO: AI-driven telemedicine for chronic and neurological conditions using neuroplasticity science.
Jogo Health was founded with the mission to leverage the science of neuroplasticity to treat chronic and neurological conditions through telemedicine. The company's core vision is to re-establish muscle-brain connections using advanced technology. Jogo Health offers an AI-driven mobile app and wearable sensors designed to address chronic pain, stroke, incontinence, Parkinson's tremors, and other movement disorders. Their market focus includes patients suffering from these conditions, as well as healthcare providers looking for innovative treatment solutions.
Notable figures affiliated with Jogo Health include experts on their Medical Advisory Board and Board of Directors, who bring extensive experience in neurology and pain management. The company has achieved significant milestones, including the development of clinically validated treatments and partnerships with healthcare institutions. Jogo Health's impact is evident in its ability to improve patient outcomes through non-invasive, tech-driven therapies, positioning it as a leader in the telemedicine space for chronic and neurological conditions.

Jeevam Health
jeevamhealth.com

Play-it Health
playithealth.com

NeuroTechR3
neurotechr3.com

Chess Health
chess.health

Mios Health

NeuroPath
neuropath.life

Reactiv
reactivrehab.com

HealthTechApps
healthtechapps.com

Curv Health

metaMe Health
metamehealth.com

AndHealth
andhealth.com

Kivo Health
kivohealth.com

NewTouch Digital

Undahealth
undahealth.com

JuneBrain
junebrain.com
Companies similar to Jogo Health include Jeevam Health, Play-it Health, NeuroTechR3 and Chess Health.
Jogo Health was founded in 2019.
Jogo Health's headquarters is located in Bridgewater Township, NJ, US.
Jogo Health's most recent funding round was for $3.3M (USD) in August 2023.
As of Aug 25, 2023, Jogo Health has raised a total of $10.4M (USD).
Jogo Health has 83 employees as of Feb 5, 2024.